Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Investing

Novartis : NVS

All Novartis Articles

135 Articles

Jon C. Ogg | Oct 24, 2017 at 12:25 PM EDT

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Here are 13 featured spin-offs already underway and potential spin-offs that could be seen in 2017 and into 2018 that…

Jon C. Ogg | Sep 13, 2017 at 7:15 AM EDT

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown…

Chris Lange | Jul 7, 2017 at 8:50 AM EDT

Why Conatus Pharma Wins With Newest Licensing Agreement

Conatus Pharmaceuticals saw its shares make a handy gain on Friday after the firm announced an exclusive license agreement with…

Jon C. Ogg | Jul 5, 2017 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: BHP Billiton, Capital One, Chemours, Constellation Brands, Novartis, Teradyne, Weyerhaeuser and More

The top analyst upgrades, downgrades and other research calls from Wednesday include BHP Billiton, Capital One, Chemours, Constellation Brands, Novartis,…

Jon C. Ogg | Mar 8, 2017 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: Chevron, Novartis, Randgold, Urban Outfitters, Vodafone and Many More

The top analyst upgrades, downgrades and initiations seen on Wednesday include Chevron, Novartis, Randgold Resources, Urban Outfitters and Vodafone.

Lee Jackson | Feb 9, 2017 at 10:15 AM EST

UBS Makes First Big 2017 Addition to Dividend Rulers Stocks List

The UBS Dividend Ruler portfolio continues to outperform the overall market on a long-term basis, and we continue to think…

Chris Lange | Dec 20, 2016 at 8:50 AM EST

Conatus More Than Doubles on Key License Collaboration Agreement

Conatus Pharmaceuticals saw its shares more than double early on Tuesday after the company reported an exclusive collaboration and license…

Paul Ausick | Dec 8, 2016 at 4:04 PM EST

FitBit, Gilead Sciences in Thursday’s 52-Week Low Club

December 8, 2016: Here are four stocks trading with relatively heavy volume among 34 equities making new 52-week lows in…

Paul Ausick | Nov 22, 2016 at 4:04 PM EST

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

November 22, 2016: Here are four stocks trading with relatively heavy volume among 38 equities making new 52-week lows in…

Lee Jackson | Oct 13, 2016 at 10:40 AM EDT

Top 5 Jefferies Big Pharma Stock Picks for Q4

A new Jefferies research report features top pharmaceutical picks for the fourth quarter. Any of these top picks make good…

Chris Lange | Sep 13, 2016 at 10:25 AM EDT

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…

Lee Jackson | Aug 5, 2016 at 10:20 AM EDT

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

A new Jefferies research report features the firm's top pharmaceutical stock picks in order of preference, and AbbVie stays in…

Jon C. Ogg | May 24, 2016 at 4:48 PM EDT

PDL’s Next Acquisition Target Focus Is on Hypertension

PDL BioPharma Inc. (NASDAQ: PDLI) has now shown where its next revenue stream will be coming from. The company announced…

Lee Jackson | Apr 21, 2016 at 8:25 AM EDT

4 Top Jefferies Dividend-Paying Value Stocks to Buy Now

In a recent research report from Jefferies, as they do every week, the analysts highlight their top value ideas to…

Lee Jackson | Apr 5, 2016 at 8:55 AM EDT

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

Tuesday’s top analyst upgrades, downgrades and initiations include AT&T, Capital One, Cisco, Novartis, Sprint and Starbucks.

1 2 3 4 5 6 … 9

Novartis : NVS

All Novartis Articles

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Why Conatus Pharma Wins With Newest Licensing Agreement

Top Analyst Upgrades and Downgrades: BHP Billiton, Capital One, Chemours, Constellation Brands, Novartis, Teradyne, Weyerhaeuser and More

Top Analyst Upgrades and Downgrades: Chevron, Novartis, Randgold, Urban Outfitters, Vodafone and Many More

UBS Makes First Big 2017 Addition to Dividend Rulers Stocks List

Conatus More Than Doubles on Key License Collaboration Agreement

FitBit, Gilead Sciences in Thursday’s 52-Week Low Club

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

Top 5 Jefferies Big Pharma Stock Picks for Q4

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

PDL’s Next Acquisition Target Focus Is on Hypertension

4 Top Jefferies Dividend-Paying Value Stocks to Buy Now

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Live Nasdaq Composite: Semiconductor Stumble Tests the Market’s AI Conviction

If You Bought SOXQ During the March 2026 Selloff, You’re Sitting on a Triple-Digit Year

Virgin Galactic Surges 14%, Rocket Lab Gains 6% as SpaceX IPO Roadshow Fuels the Space Trade

Investor Turned $258K to $3M This Year Using This Micron ETF

One in Three Twentysomethings Has Two Jobs and 58% Have a Side Hustle. That's Not a Trend, It's a Retirement Warning Sign

Medicare's IRMAA Cliff Just Erased Your 2026 Social Security Raise. Here's Why

If You Bought SOXQ During the March 2026 Selloff, You’re Sitting on a Triple-Digit Year

Virgin Galactic Surges 14%, Rocket Lab Gains 6% as SpaceX IPO Roadshow Fuels the Space Trade

Novartis : NVS

All Novartis Articles

13 Spin-Offs Set to Radically Change Top Companies in 2017 and 2018

Merrill Lynch Top Health Care Stock Picks for September: Focus on Large Cap Biotech

Why Conatus Pharma Wins With Newest Licensing Agreement

Top Analyst Upgrades and Downgrades: BHP Billiton, Capital One, Chemours, Constellation Brands, Novartis, Teradyne, Weyerhaeuser and More

Top Analyst Upgrades and Downgrades: Chevron, Novartis, Randgold, Urban Outfitters, Vodafone and Many More

UBS Makes First Big 2017 Addition to Dividend Rulers Stocks List

Conatus More Than Doubles on Key License Collaboration Agreement

FitBit, Gilead Sciences in Thursday’s 52-Week Low Club

AstraZeneca, Novartis Drop into Tuesday’s 52-Week Low Club

Top 5 Jefferies Big Pharma Stock Picks for Q4

Jefferies Issues Top Pharma and Biohealth Stocks to Buy

Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick

PDL’s Next Acquisition Target Focus Is on Hypertension

4 Top Jefferies Dividend-Paying Value Stocks to Buy Now

Top Analysts Upgrades and Downgrades: AT&T, Capital One, Cisco, Novartis, Sprint, Starbucks and More

Stock Market Live June 4, 2026: S&P 500 (SPY) Fall as Broadcom Sinks

Live Nasdaq Composite: Semiconductor Stumble Tests the Market’s AI Conviction

If You Bought SOXQ During the March 2026 Selloff, You’re Sitting on a Triple-Digit Year

Virgin Galactic Surges 14%, Rocket Lab Gains 6% as SpaceX IPO Roadshow Fuels the Space Trade

Investor Turned $258K to $3M This Year Using This Micron ETF

Featured Reads

One in Three Twentysomethings Has Two Jobs and 58% Have a Side Hustle. That's Not a Trend, It's a Retirement Warning Sign

Medicare's IRMAA Cliff Just Erased Your 2026 Social Security Raise. Here's Why